Literature DB >> 13460736

Modern treatment of placenta previa; a study of 234 cases.

W B McGEE, T A O'SULLIVAN.   

Abstract

Study was made of 234 cases of placenta previa occurring in 48,752 deliveries at one hospital during the period 1947-1956. There was no maternal mortality. The uncorrected fetal mortality rate for all weight groups was 21.4 per cent. The rate varied from 88 per cent in babies under 1,500 grams to 5.7 per cent in babies over 2,500 grams. Initial conservative management to permit gestation to continue as close to term as possible is advisable. Ultimate termination of the pregnancy by cesarean section under spinal anesthesia gave the best results. The incidence of transverse and breech presentations in association with placenta previa was inordinately high. A progressive trend toward more conservative treatment of placenta previa was noted in the present series, with a concomitant reduction in fetal mortality rate.

Keywords:  PLACENTA PRAEVIA

Mesh:

Year:  1957        PMID: 13460736      PMCID: PMC1512176     

Source DB:  PubMed          Journal:  Calif Med        ISSN: 0008-1264


  6 in total

1.  Rupture of the marginal sinus of the placenta.

Authors:  J H FERGUSON
Journal:  Am J Obstet Gynecol       Date:  1955-05       Impact factor: 8.661

2.  X-ray visualization of the placenta.

Authors:  H G WATSON
Journal:  West J Surg Obstet Gynecol       Date:  1955-03

3.  Fetal mortality in placenta previa.

Authors:  L T HIBBARD
Journal:  Obstet Gynecol       Date:  1956-11       Impact factor: 7.661

4.  The role of marginal sinus rupture in antenatal hemorrhage.

Authors:  J S FISH; R A BARTHOLOMEW; E D COLVIN; W H GRIMES
Journal:  Am J Obstet Gynecol       Date:  1951-01       Impact factor: 8.661

5.  The management of placenta previa; a review of 201 cases with emphasis on conservatism.

Authors:  H W JOHNSON
Journal:  Am J Obstet Gynecol       Date:  1950-06       Impact factor: 8.661

6.  Conservative management of third trimester bleeding.

Authors:  E W OVERSTREET; H F TRAUT
Journal:  Calif Med       Date:  1951-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.